HDAC inhibitors may offer new strategy for reversing fibrotic wall around pancreatic tumors

In a Q2 financial report, BioNTech announced that it would quit the joint development of acasunlimab with Genmab as it focuses on its antibody drug

Biotech­nol­o­gy In­no­va­tion Or­ga­ni­za­tion vice chair John Crow­ley will be­come the next CEO of the in­dus­try’s ad­vo­ca­cy and lob­by­ing or­ga­ni­za­tion on March 4, pick­ing an in­sid­er